ST. ROSE DOMINICAN - SIENA
The Sunshine Act requires manufacturers to report payments to teaching hospitals as institutions, separately from payments to individual physicians. These figures are money reported to the hospital itself — most of it research funding and grants, not compensation to any named doctor.
- Total reported
- $1.4M
- Transactions
- 455
- Companies
- 28
- Average per transaction
- $3,023
Who reported the payments
| Roche TCRC, Inc. | $319,306 |
| Exelixis Inc. | $294,919 |
| UCB SA | $129,526 |
| Acell, Inc. | $126,082 |
| Genentech, Inc. | $102,938 |
| AbbVie | $77,289 |
| F. Hoffmann-la Roche AG | $71,827 |
| Medtronic | $54,182 |
| Intercept Pharmaceuticals, Inc. | $52,325 |
| Intercept Pharma Europe Ltd. | $44,022 |
| Providence Medical Technology, Inc. | $22,679 |
| Sanofi | $22,026 |
| Smith+Nephew | $20,809 |
| ZOLL Circulation Inc | $10,020 |
| Eisai Inc. | $8,448 |
| Bausch Health US, LLC | $5,114 |
| Aesculap Implant Systems, LLC | $4,684 |
| Siemens Medical Solutions USA, Inc. | $3,425 |
| UCB, Inc. | $1,500 |
| Merz Pharmaceuticals, LLC | $1,500 |
| Haemonetics Corporation | $986 |
| Intuitive Surgical | $950 |
| Angiodynamics, Inc. | $426 |
| Amgen | $193 |
| Stryker | $131 |
| Zimmer Biomet | $106 |
| AVEO Pharmaceuticals, Inc. | $40 |
| Olympus America Inc. | $31 |